Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial

Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 5

Abstract

The online version of this article (doi:10.1208/s12248-014-9631-6) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Kelong Han, Jin Jin, Mauricio Maia, John Lowe, Martina A. Sersch, David E. Allison

Keywords

Related Articles

Gomisin A is a Novel Isoform-Specific Probe for the Selective Sensing of Human Cytochrome P450 3A4 in Liver Microsomes and Living Cells

The online version of this article (doi:10.1208/s12248-015-9827-4) contains supplementary material, which is available to authorized users.

Drug Repurposing: Far Beyond New Targets for Old Drugs

Repurposing drugs requires finding novel therapeutic indications compared to the ones for which they were already approved. This is an increasingly utilized strategy for finding novel medicines, one that capitalizes on p...

Inhibition of carboxyethylphosphoramide mustard formation from 4-hydroxycyclophosphamide by carmustine

It has been reported that the toxicity of carmustine (BCNU) cyclophosphamide (CY)/etoposide regimen (when BCNU is split into 4 doses) is less than that of BCNU/CY/cisplatin regimen (when the same amount of BCNU is admini...

Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate

In vitro–in vivo correlations (IVIVC) are predictive mathematical models describing the relationship between dissolution and plasma concentration for a given drug compound. The traditional deconvolution/convoluti...

The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in hep G2 cells

The development of macromolecules as drugs and drug carriers requires knowledge of their fate in cells. To this end, we studied the internalization and subcellular fate of N-(2-hydroxypropyl)methacrylamide (HPMA) copolym...

Download PDF file
  • EP ID EP681086
  • DOI  10.1208/s12248-014-9631-6
  • Views 63
  • Downloads 0

How To Cite

Kelong Han, Jin Jin, Mauricio Maia, John Lowe, Martina A. Sersch, David E. Allison (2014). Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial. The AAPS Journal, 16(5), -. https://www.europub.co.uk/articles/-A-681086